Tuesday, October 12, 2010

SGLT2 Inhibition: A New Kidney-based Strategy to Reduce Hyperglycemia

New and emerging type 2 diabetes therapies with novel MOAs that reduce hyperglycemia while preserving insulin secretion, preventing hypoglycemia and controlling body weight. Explore renal glucose reabsorption via selective inhibition of the sodium-glucose transporter-2.

Please go through below link to understand more.

Center for HealthCare Education


No comments:

Post a Comment